Zum Hauptinhalt springen

Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV.

Dirajlal-Fargo, S ; Strah, M ; et al.
In: AIDS (London, England), Jg. 38 (2024-02-01), Heft 2, S. 177
academicJournal

Titel:
Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV.
Autor/in / Beteiligte Person: Dirajlal-Fargo, S ; Strah, M ; Ailstock, K ; Sattar, A ; Karungi, C ; Nazzinda, R ; Funderburg, N ; Kityo, C ; Musiime, V ; McComsey, GA
Zeitschrift: AIDS (London, England), Jg. 38 (2024-02-01), Heft 2, S. 177
Veröffentlichung: 1998- : London, England : Lippincott Williams & Wilkins ; <i>Original Publication</i>: London : Gower Academic Journals, c1987-, 2024
Medientyp: academicJournal
ISSN: 1473-5571 (electronic)
DOI: 10.1097/QAD.0000000000003741
Schlagwort:
  • Humans
  • Female
  • Adolescent
  • Male
  • Longitudinal Studies
  • Prospective Studies
  • Uganda epidemiology
  • Inflammation complications
  • Insulin Resistance physiology
  • HIV Infections complications
  • HIV Infections metabolism
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Publication Type: Journal Article
  • Language: English
  • [AIDS] 2024 Feb 01; Vol. 38 (2), pp. 177-184. <i>Date of Electronic Publication: </i>2023 Sep 29.
  • MeSH Terms: Insulin Resistance* / physiology ; HIV Infections* / complications ; HIV Infections* / metabolism ; Humans ; Female ; Adolescent ; Male ; Longitudinal Studies ; Prospective Studies ; Uganda / epidemiology ; Inflammation / complications
  • References: UNICEF. HIV Global and regional trends. New York, January 2023. ; Hazra R, Siberry GK, Mofenson LM. Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection . Ann Rev Med 2010; 61:169–185. ; Innes S, Patel K. Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings . Curr Opin HIV AIDS 2018; 13:187–195. ; Alves Junior CAS, Martins PC, Lima LRA, Silva DAS. What anthropometric indicators are associated with insulin resistance? Cross-sectional study on children and adolescents with diagnosed human immunodeficiency virus . Sao Paulo Med J 2022; 140:94–100. ; Geffner ME, Patel K, Miller TL, Hazra R, Silio M, Van Dyke RB, et al. Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort study . Horm Res Paediatr 2011; 76:386–391. ; Aldrovandi GM, Lindsey JC, Jacobson DL, Zadzilka A, Sheeran E, Moye J, et al. Morphologic and metabolic abnormalities in vertically HIV-infected children and youth . AIDS (London, England) 2009; 23:661–672. ; Chantry CJ, Hughes MD, Alvero C, Cervia JS, Meyer WA 3rd, Hodge J, et al. Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy . Pediatrics 2008; 122:e129–e138. ; Gojanovich GS, Jacobson DL, Jao J, Russell JS, Van Dyke RB, Libutti DE, et al. Mitochondrial dysfunction and insulin resistance in pubertal youth living with perinatally acquired HIV . AIDS Res Hum Retroviruses 2020; 36:703–711. ; Takemoto JK, Miller TL, Wang J, Jacobson DL, Geffner ME, Van Dyke RB, Gerschenson M. Insulin resistance in HIV-infected youth is associated with decreased mitochondrial respiration . AIDS (London, England) 2017; 31:15–23. ; Espiau M, Yeste D, Noguera-Julian A, González-Tomé MI, Falcón-Neyra L, Gavilán C, et al. Metabolic syndrome in children and adolescents living with HIV . Pediatr Infect Dis J 2016; 35:e171–e176. ; Arpadi S, Shiau S, Strehlau R, Martens L, Patel F, Coovadia A, et al. Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy . Arch Dis Child 2013; 98:258–264. ; Dirajlal-Fargo S, Moser C, Brown TT, Kelesidis T, Dube MP, Stein JH, et al. Changes in insulin resistance after initiation of raltegravir or protease inhibitors with tenofovir-emtricitabine: AIDS Clinical Trials Group A5260 s . Open Forum Infect Dis 2016; 3:ofw174. ; Dirajlal-Fargo S, Musiime V, Cook A, Mirembe G, Kenny J, Jiang Y, et al. Insulin resistance and markers of inflammation in HIV-infected Ugandan children in the CHAPAS-3 Trial . Pediatr Infect Dis J 2017; 36:761–767. ; Dirajlal-Fargo S, Shan L, Sattar A, Bowman E, Gabriel J, Kulkarni M, et al. Insulin resistance and intestinal integrity in children with and without HIV infection in Uganda . HIV Med 2020; 21:119–127. ; Frigati LJ, Jao J, Mahtab S, Asafu Agyei NA, Cotton MF, Myer L, Zar HJ. Insulin resistance in South African youth living with perinatally acquired HIV receiving antiretroviral therapy . AIDS Res Hum Retroviruses 2019; 35:56–62. ; Davies C, Vaida F, Otwombe K, Cotton MF, Browne S, Innes S. Longitudinal comparison of insulin resistance and dyslipidemia in children with and without perinatal HIV infection in South Africa . AIDS (London, England) 2023; 37:523–533. ; Pedro MN, Rocha GZ, Guadagnini D, Santos A, Magro DO, Assalin HB, et al. Insulin resistance in HIV-patients: causes and consequences . Front Endocrinol 2018; 9:514. ; Sim JH, Mukerji SS, Russo SC, Lo J. Gastrointestinal dysfunction and HIV comorbidities . Curr HIV/AIDS Rep 2021; 18:57–62. ; Hills SA, Balkau B, Coppack SW, Dekker JM, Mari A, Natali A, et al. The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives . Diabetologia 2004; 47:566–570. ; Kozakova M, Natali A, Dekker J, Beck-Nielsen H, Laakso M, Nilsson P, et al. Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study . Arterioscler Thromb Vasc Biol 2013; 33:1409–1417. ; Høgh J, Hove-Skovsgaard M, Gelpi M, Jensen AMR, Gerstoft J, Benfield T, et al. Insulin resistance in people living with HIV is associated with exposure to thymidine analogues and/or didanosine and prior immunodeficiency . BMC Infect Dis 2022; 22:503. ; Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man . Diabetologia 1985; 28:412–419. ; World Health Organization. Body Mass index-for-age toolkit. https://www.who.int/tools/growth-reference-data-for-5to19-years/indicators/bmi-for-age . [Accessed 30 November 2023]. ; McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, et al. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV . AIDS (London, England) 2007; 21:2473–2482. ; Montoya JL, Jankowski CM, O’Brien KK, Webel AR, Oursler KK, Henry BL, et al. Evidence-informed practical recommendations for increasing physical activity among persons living with HIV . AIDS 2019; 33:931–939. ; Butte NF, Watson KB, Ridley K, Zakeri IF, McMurray RG, Pfeiffer KA, et al. A youth compendium of physical activities: activity codes and metabolic intensities . Med Sci Sports Exerc 2018; 50:246–256. ; Dalla Pozza R, Ehringer-Schetitska D, Fritsch P, Jokinen E, Petropoulos A, Oberhoffer R. Intima media thickness measurement in children: a statement from the Association for European Paediatric Cardiology (AEPC) Working Group on Cardiovascular Prevention endorsed by the Association for European Paediatric Cardiology . Atherosclerosis 2015; 238:380–387. ; Dirajlal-Fargo S, Albar Z, Bowman E, Labbato D, Sattar A, Karungi C, et al. Subclinical vascular disease in children with human immunodeficiency virus in Uganda is associated with intestinal barrier dysfunction . Clin Infect Dis 2020; 71:3025–3032. ; Funderburg NT, Jiang Y, Debanne SM, Storer N, Labbato D, Clagett B, et al. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy . Clin Infect Dis 2014; 58:588–595. ; Republic of Uganda Ministry of Health. Consolidated guidelines for the prevention and treatment of HIV and AIDS in Uganda. February 2020. https://dsduganda.com/wp-content/uploads/2023/05/Consolidated-HIV-and-AIDS-Guidelines-20230516.pdf . [Accessed 30 November 2023]. ; Geffner ME, Patel K, Jacobson DL, Wu J, Miller TL, Hazra R, et al. Changes in insulin sensitivity over time and associated factors in HIV-infected adolescents . AIDS (London, England) 2018; 32:613–622. ; Paganella MP, Cohen RA, Harris DR, de Souza Kuchenbecker R, Sperhacke RD, Kato SK, et al. Association of dyslipidemia and glucose abnormalities with antiretroviral treatment in a cohort of HIV-infected Latin American Children . J Acquir Immune Defic Syndr 19992017; 74:e1–e8. ; Innes S, Abdullah KL, Haubrich R, Cotton MF, Browne SH. High prevalence of dyslipidemia and insulin resistance in HIV-infected prepubertal African children on antiretroviral therapy . Pediatr Infect Dis J 2016; 35:e1–e7. ; Reis LCd, Rondó PHdC, Marques HHdS, Andrade SBd. Dyslipidaemia and insulin resistance in vertically HIV-infected children and adolescents . Trans Royal Soc Trop Med Hygiene 2011; 105:197–203. ; Jeffery AN, Metcalf BS, Hosking J, Streeter AJ, Voss LD, Wilkin TJ. Age before stage: insulin resistance rises before the onset of puberty: a 9-year longitudinal study (EarlyBird 26) . Diabetes Care 2012; 35:536–541. ; Peplies J, Jiménez-Pavón D, Savva SC, Buck C, Günther K, Fraterman A, et al. Percentiles of fasting serum insulin, glucose, HbA1c and HOMA-IR in prepubertal normal weight European children from the IDEFICS cohort . Int J Obes 2014; 38:S39–S47. ; Hulgan T. Factors associated with insulin resistance in adults with HIV receiving contemporary antiretroviral therapy: a brief update . Curr HIV/AIDS Rep 2018; 15:223–232. ; Shikuma CM, Chow DC, Gangcuangco LM, Zhang G, Keating SM, Norris PJ, et al. Monocytes expand with immune dysregulation and is associated with insulin resistance in older individuals with chronic HIV . PLoS One 2014; 9:e90330. ; O’Malley TK, Burdo TH, Robinson JA, Fitch KV, Grinspoon SK, Srinivasa S. Acute hyperinsulinemia effects on systemic markers of immune activation in HIV . AIDS (London, England) 2017; 31:1771–1773. ; Pedersen KK, Pedersen M, Trøseid M, Gaardbo JC, Lund TT, Thomsen C, et al. Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction . J Acquir Immune Defic Syndr 2013; 64:425–433. ; Moreno-Pérez Ó, Giner L, Reus S, Boix V, Alfayate R, Frances R, et al. Impact of circulating bacterial DNA in long-term glucose homeostasis in nondiabetic patients with HIV infection: cohort study . Eur J Clin Microbiol Infect Dis 2018; 37:313–318. ; El Kamari V, Moser C, Hileman CO, Currier JS, Brown TT, Johnston L, et al. Lower pretreatment gut integrity is independently associated with fat gain on antiretroviral therapy . Clin Infect Dis 2019; 68:1394–1401. ; Dirajlal-Fargo S, Albar Z, Bowman E, Labbato D, Sattar A, Karungi C, et al. Increased monocyte and T-cell activation in treated HIV+ Ugandan children: associations with gut alteration and HIV factors . AIDS (London, England) 2020; 34:1009–1018. ; Dirajlal-Fargo S, Strah M, Ailstock K, Sattar A, Karungi C, Nazzinda R, et al. Persistent immune activation and altered gut integrity over time in a longitudinal study of Ugandan youth with perinatally acquired HIV . Front Immunol 2023; 14:1165964. ; Eddy D, Schlessinger L, Kahn R, Peskin B, Schiebinger R. Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis . Diabetes Care 2009; 32:361–366. ; Brener MI, Post WS, Haberlen SA, Zhang L, Palella FJ Jr, Jacobson LP, et al. Comparison of insulin resistance to coronary atherosclerosis in human immunodeficiency virus infected and uninfected men (from the Multicenter AIDS Cohort Study) . Am J Cardiol 2016; 117:993–1000. ; Valcour V, Rubin LH, Tien P, Anastos K, Young M, Mack W, et al. Human immunodeficiency virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: a study of the Women's Interagency HIV Study (WIHS) . J Neurovirol 2015; 21:415–421. ; Kibirige D, Lumu W, Jones AG, Smeeth L, Hattersley AT, Nyirenda MJ. Understanding the manifestation of diabetes in sub Saharan Africa to inform therapeutic approaches and preventive strategies: a narrative review . Clin Diabetes Endocrinol 2019; 5:2.
  • Grant Information: UL1 TR002548 United States TR NCATS NIH HHS; U01 AI168630 United States AI NIAID NIH HHS; R21 DK127522 United States DK NIDDK NIH HHS; UM1 TR004528 United States TR NCATS NIH HHS; R21 HD106579 United States HD NICHD NIH HHS; K23 HD088295 United States HD NICHD NIH HHS
  • Entry Date(s): Date Created: 20231003 Date Completed: 20231221 Latest Revision: 20240423
  • Update Code: 20240423
  • PubMed Central ID: PMC10872911

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -